Dr. Scott Oh

Dr. Alan Lee, a radiation oncologist from UCLA, shares insights on photon and proton therapies, explaining their practical differences and costs. Dr. Scott Oh, an interventional pulmonologist at USC, discusses innovative bronchoscopic approaches, including robotic-assisted techniques. Dr. Rob Suh from UCLA highlights the evolution of lung ablation technologies and addresses the complexities of managing complications like pneumothorax. Together, they explore patient selection criteria, the limitations of traditional RECIST criteria, and the advancements aiming to enhance lung cancer treatment outcomes.

Dr. Scott Atai, a general thoracic surgeon at USC, and Dr. Scott Oh, an interventional pulmonologist, join the discussion on innovative lung cancer treatments. They explore the shift from traditional open thoracotomy to robotic and minimally invasive techniques. The duo emphasizes the importance of accurate mediastinal staging and the role of advanced bronchoscopic methods. They also share insights on managing multifocal lung cancers and preserving lung function while employing a multidisciplinary and personalized approach for long-term outcomes.

Dr. Scott Oh, an interventional pulmonologist, Dr. Rob Suh, a thoracic interventional radiologist, and Dr. Alan Lee, a radiation oncologist, dive into the intricacies of lung cancer treatment. They explore why combining biopsy and ablation may become standard for high-probability cases. The discussions cover sedation strategies, the pros and cons of various biopsy techniques, and groundbreaking advancements like robotic and cryo-biopsy. Their focus on personalized patient care and multidisciplinary collaboration offers valuable insights into improving thoracic oncology outcomes.